Spesolimab Response in a Girl With Acrodermatitis Continua of Hallopeau
JAMA Dermatology · 01.04.2024 · 160 (4) · 476
DOI: 10.1001/jamadermatol.2023.6349 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Dermatology, erschienen am 01.04.2024. Verfasst von Youcong Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Acrodermatitis, Psoriasis, Exanthema, Skin Diseases, Vesiculobullous. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
This case report summarizes the treatment of acrodermatitis continua of Hallopeau with spesolimab in a 9-year-old girl.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zitieren
APA
Wang, Y., Zhang, L., Zheng, J., Li, X., & Chen, L. (2024). Spesolimab Response in a Girl With Acrodermatitis Continua of Hallopeau. JAMA Dermatology, 160(4), 476. https://doi.org/10.1001/jamadermatol.2023.6349
Vancouver
Wang Y, Zhang L, Zheng J, Li X, Chen L. Spesolimab Response in a Girl With Acrodermatitis Continua of Hallopeau. JAMA Dermatology. 2024;160(4):476. doi:10.1001/jamadermatol.2023.6349
BibTeX
@article{Wang2024,
author = {Wang, Youcong and Zhang, Li and Zheng, Jie and Li, Xia and Chen, Lihong},
title = {Spesolimab Response in a Girl With Acrodermatitis Continua of Hallopeau},
journal = {JAMA Dermatology},
year = {2024},
volume = {160},
number = {4},
pages = {476},
doi = {10.1001/jamadermatol.2023.6349}
}
EUVIMED